Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
Nan Li(National Institutes of Health), Mitchell Ho(National Institutes of Health)
Cited by 146
Related Papers
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
|Nature Communications|2015|154
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
|Nature Communications|2023|65
Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma
|Scientific Reports|2016|63
Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
|Scientific Reports|2021|39